South Africa has secured a R1.5 billion ($90 million) deal with the European Investment Bank and Biovac to build Africa’s first fully integrated end-to-end vaccine manufacturing plant. Set for completion by 2028, the facility will initially produce oral cholera vaccines before expanding to polio, pneumonia, and meningitis vaccines, with capacity for 40 million doses annually. The project is expected to create over 340 skilled jobs and 7,000 indirect positions. The announcement comes amid heightened concerns over a recent hantavirus outbreak linked to a cruise ship, though South Africa’s cabinet praised its swift diagnostic response and emphasized the virus has not been detected in African rodents.
In-Depth:
South Africa has secured a Europe-backed $90 million deal to build Africa’s first fully integrated vaccine plant, a project expected to create over 7,000 jobs amid growing hantavirus outbreak fears.
- South Africa secured a R1.5 billion deal with the European Investment Bank and Biovac to build Africa’s first fully integrated conclude-to-conclude vaccine manufacturing plant.
- The facility, set for completion by 2028, will produce oral cholera vaccines initially, later expanding to polio, pneumonia, and meningitis vaccines.
- The project strengthens economic ties with the European Union as South Africa diversifies partnerships amid strained relations with the United States.
- South Africa’s cabinet also highlighted a swift hantavirus response, emphasizing the nation’s strong disease surveillance and medical expertise.
The agreement marks a major step in Africa’s push to reduce depconcludeence on imported vaccines after the Covid 19 pandemic exposed weaknesses in global pharmaceutical supply chains.
It also comes amid renewed focus on infectious disease preparedness following the recent hantavirus outbreak linked to a luxury expedition cruise ship, where three passengers, including two critically ill individuals, were evacuated from Cape Verde to Europe for specialist treatment.
At the same time, the deal reflects Pretoria’s deepening economic and strategic ties with the European Union as relations with the United States remain strained following months of diplomatic and trade tensions.
Africa’s vaccine ambitions gain momentum
Cabinet stated the facility, scheduled for completion by 2028, will initially produce oral cholera vaccines before later expanding into vaccines for polio, pneumonia and meningitis.
Once fully operational, the plant is expected to produce up to 40 million doses annually, significantly strengthening Africa’s healthcare resilience and supply-chain security.
Although Africa already hosts several vaccine manufacturing facilities and projects, most operate on a tinyer scale than plants in Europe, India and China and remain heavily depconcludeent on imported ingredients for final filling and packaging.
The Biovac project is being positioned as Africa’s first fully integrated conclude-to-conclude multi-vaccine manufacturing facility, allowing more stages of vaccine development and production to take place locally as the continent pushes to strengthen pharmaceutical indepconcludeence.
In line with that ambition, the project supports the Africa Centres for Disease Control and Prevention’s tarreceive for the continent to produce 60% of its vaccine necessarys locally by 2040.
The investment is also expected to create more than 340 skilled jobs and around 7,000 indirect jobs while further supporting technology transfer, pharmaceutical innovation and long-term healthcare resilience across the continent.
![The MV Hondius cruise ship leaves Cape Verde under health restrictions after a deadly Andes hantavirus outbreak killed three passengers and triggered international quarantine measures. [Photo by AFP via Getty Images]](https://ocdn.eu/pulscms/MDA_/0fe19fa20f81daeae8083342b6203680.jpg)
South Africa turns further toward Europe
The financing package reinforces Europe’s growing role in Africa’s healthcare and industrial ambitions as several African governments seek to diversify strategic partnerships beyond traditional Western allies.
Pretoria’s relationship with Washington has yet to fully recover following tensions over trade, foreign policy positioning and South Africa’s stance on several global conflicts.
Analysts state the strain has accelerated South Africa’s efforts to deepen economic engagement with the European Union, China and other partners less likely to pressure Pretoria diplomatically.
The vaccine project also arrives at a difficult moment for South Africa’s economy, which continues to face sluggish growth, weak manufacturing activity, persistent unemployment and infrastructure bottlenecks.
Government highlights hantavirus response
Alongside the vaccine announcement, South Africa’s cabinet praised the National Institute for Communicable Diseases for diagnosing two hantavirus cases within 24 hours after patients from the MV Hondius cruise ship were admitted to a Gauteng hospital.
Cabinet also commconcludeed the Department of Health for rapidly conducting contact tracing before the diagnosis was confirmed.
The government sought to calm fears of a wider outbreak, stateing scientists had confirmed that hantavirus has not been detected in rats in South Africa or elsewhere on the African continent despite concerns linked to rodent infestations in some municipalities.
